US Patent 11174240 Crystalline solid compound of 3-phenyl-4-propyl-1-(pyridin-2-yl)-1H-pyrazol-5-ol hydrochloride
Patent 11174240 was granted and assigned to Aptabio Therapeutics on November, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
April 20, 2018
Date of Patent
November 16, 2021
Patent Applicant
Patent Application Number
16605380
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11174240 Crystalline solid compound of 3-phenyl-4-propyl-1-(pyridin-2-yl)-1H-pyrazol-5-ol hydrochloride
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
